RT Journal Article
SR Electronic
T1 Modeling Cerebral Hemodynamics Using BOLD Magnetic Resonance Imaging and its Application in Mild Cognitive Impairment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.23.20018846
DO 10.1101/2020.02.23.20018846
A1 Henley, B.C.
A1 Okafor, M.O.
A1 Hajjar, I.
YR 2020
UL http://medrxiv.org/content/early/2020/02/26/2020.02.23.20018846.abstract
AB Objective This study develops a procedure and related analytical methods for deriving indices of cerebral hemodynamics in the magnetic resonance imaging (MRI) setting using resting state recordings of systemic blood pressure, pulse rate, and end-tidal CO2 synchronized with the MRI image acquisitions of blood oxygenation level dependent (BOLD) data as a measure of cerebral perfusion.Methods We employed the concept of Principal Dynamic Modes (PDM) to model the effect of three determinants of cerebral perfusion: mean arterial blood pressure (MABP), end-tidal CO2 (PETCO2), and pulse rate (PR). The relation between these signals and the BOLD signal were used respectively to quantify cerebral autoregulation (CA), CO2 vasoreactivity (CVR), and pulse rate reactivity (PRR).Results Hemodynamic indices were obtained from 129 participants with normal cognition (NC) and mild cognitive impairment (MCI). CA was reduced in MCI compared to NC in the parietal lobe, CVR was reduced in MCI in the occipital and temporal lobes, and PRR was reduced in the frontal, parietal, occipital and temporal lobes. Reduced CVR and PRR were associated with worse cognitive scores including memory and executive function.Conclusion Employed acquisition and analysis of MRI hemodynamic identified cerebral hemodynamic alterations in MCI, related to PR and ETCO2 changes.Significance This modeling approach may offer a novel way to clinically assess cerebral hemodynamics during MRI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants AG051633 (Dr Hajjar), AG057470-01 (Dr Hajjar), and AG042127 (Dr Hajjar), from the NIA/NIH.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request